Use Of SB-705498 In The Acute Treatment Of Migraine

Clinical trial NCT00269022 · COMPLETED

Trial details

NCT number: NCT00269022
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Migraine, Acute

Start date: 2006-01-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.